Mubadala Investment Company in Evotec SE
Completed. First disclosed November 16, 2021, in a Schedule 13D (source).
- Investor
- Mubadala Investment Company (United Arab Emirates)
- Target
- Evotec SE (EDGAR CIK 1412558)
- Target country
- Germany
- Sector
- Health and Life Sciences (SIC 2834)
- First disclosed
- November 16, 2021, Schedule 13D
- Amount
- Not stated
- Stake at first disclosure
- 6.6%
- Latest stated stake
- 6.6% (November 16, 2021)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| November 16, 2021 | Schedule 13D | 6.6% | View |
Cite: Middle East Forum, “Mubadala Investment Company in Evotec SE,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/mubadala-evotec-se-1412558/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.